Oral decitabine–cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study
Titel:
Oral decitabine–cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study
Auteur:
Garcia-Manero, Guillermo McCloskey, James Griffiths, Elizabeth A Yee, Karen W L Zeidan, Amer M Al-Kali, Aref Deeg, H Joachim Patel, Prapti A Sabloff, Mitchell Keating, Mary-Margaret Zhu, Nancy Gabrail, Nashat Y Fazal, Salman Maly, Joseph Odenike, Olatoyosi Kantarjian, Hagop DeZern, Amy E O’Connell, Casey L Roboz, Gail J Busque, Lambert Buckstein, Rena Amin, Harshad Randhawa, Jasleen Leber, Brian Shastri, Aditi Dao, Kim-Hien Oganesian, Aram Hao, Yong Keer, Harold N Azab, Mohammad Savona, Michael R